Advertisement

Topics

Sunovion Announces Positive Topline Results from Study Evaluating Latuda® (lurasidone HCl) in Children and Adolescents with Bipolar Depression

08:00 EST 27 Feb 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
- Phase 3 study demonstrated statistically significant and clinically meaningful improvement compared to placebo at primary endpoint - Sunovion Pharmaceuticals Inc. (Sunovion) today announced that its Phase 3 clinical...

Other Sources for this Article

Sunovion Pharmaceuticals Inc.
Kristina Coppola, 508-787-4368
Sr. Manager, Corporate Communications
kristina.coppola@sunovion.com

NEXT ARTICLE

More From BioPortfolio on "Sunovion Announces Positive Topline Results from Study Evaluating Latuda® (lurasidone HCl) in Children and Adolescents with Bipolar Depression"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pediatrics
Pediatrics is the general medicine of childhood. Because of the developmental processes (psychological and physical) of childhood, the involvement of parents, and the social management of conditions at home and at school, pediatrics is a specialty. With ...

Psychiatry
Psychiatry is the study of mental disorders and their diagnosis, management and prevention.  Conditions include schizophrenia, severe depression and panic disorders among others. There are pharmaceutical treatments as well as other therapies to help...

Depression
Depression is a serious mental health condition, where sad feelings carry on for weeks or months and interfere with your life. The symptoms include feeling unhappy most of the time (but may feel a little better in the evenings), loosing interest in lif...